Maximus vs MyStart Health

Recorded prices, access and terms.

Decision table

The entries below are recorded provider statements unless a regulatory source is linked. A provider webpage does not independently verify its licenses or quality. Maximus source · MyStart Health source.

CompareMaximusMyStart Health
Recorded monthly-plan priceNot recordedNot recorded
Recorded medication/program subtotalSeller's headline: Compounded tirzepatide $99.99/mo on a 12-month plan, $199.99/mo on a 2-month plan. It may require prepayment, a specific dose or introductory terms. The full required cost is not established.Seller's headline: Program from $299/mo, all-inclusive per its FAQ. It may require prepayment, a specific dose or introductory terms. The full required cost is not established.
Full required monthly costNot established: consultation, labs, membership, dose changes and shipping must be checkedNot established: consultation, labs, membership, dose changes and shipping must be checked
Drug type listedCompoundedBrand-name and compounded
Consultation$28-35 per visit in the record; current conditions unconfirmedFree in the record; current conditions unconfirmed
Pharmacy licenseNot independently verified. Obtain the dispensing pharmacy name and verify its state license.Not independently verified. Obtain the dispensing pharmacy name and verify its state license.
Reported states50; confirm eligibility and clinician licensing in your state50; confirm eligibility and clinician licensing in your state
CancellationCancellation reported; notice, minimum term and refund conditions unconfirmedCancellation reported; notice, minimum term and refund conditions unconfirmed
Clinician/support as reportedLicensed physicians, lab testing availableLicensed U.S. physicians, unlimited clinician access
Recorded provider check2026-11-062026-11-06

Which should you choose?

Ask each provider for the full cost at your prescribed dose, required labs and visits, the dispensing pharmacy, the clinician's state license, renewal charges and written refund terms. Compare those answers with your clinician.

Compounded drugs are not FDA-approved and do not undergo FDA review for safety, effectiveness or quality before marketing. FDA source and recommendations.

Maximus: evidence and terms

Recorded FDA letter (2026-06-08): Cited by FDA for false or misleading claims / misbranding in its telehealth marketing of compounded GLP-1 products. One of fifteen telehealth firms warned the same day. FDA letter.

Read Maximus's sourced record · Maximus source

MyStart Health: evidence and terms

Recorded FDA letter (2025-09-09): FDA found claims on mystarthealth.com for compounded GLP-1 products false or misleading, making the products misbranded under FD&C Act sections 502(a) and 502(bb). FDA letter.

Read MyStart Health's sourced record · MyStart Health source

Compare the full provider directory · Compare recorded price subtotals

Embody (paid link)

from $49/mo, 12-month plan

Visit Embody